PRO-087

DRUG2 trials

Sponsors

Laboratorios Sophia S.A de C.V.

Conditions

Dry Eye SyndromeDry Eye SyndromesLubricant AllergyTear Disorder

Phase 1

Safety and Tolerability of PRO-087 Versus Xyel Ofteno® and Systane Ultra®, on the Ocular Surface of Healthy Subjects

CompletedNCT03524157

Laboratorios Sophia S.A de C.V.Dry Eye Syndromes, Lubricant Allergy, Tear Disorder

Start: 2017-07-17End: 2018-03-27Updated: 2019-07-19

Phase 4

Efficacy and Safety of the Ophthalmic Solution PRO-087 Versus Systane ® Ultra and Ultra Preservative Free (087LATAMFIV)

CompletedNCT03223909

Laboratorios Sophia S.A de C.V.Dry Eye Syndrome

Start: 2016-10-13End: 2018-12-16Updated: 2019-10-31

Related Papers

Reexamining Ophthalmic Drugs, Safety and Tolerability in Phase 1 Clinical Trials

Therapeutics and Clinical Risk Management2021-10-013 citations